Would you like to
contribute to this site?
Osteoporosis Menu
Submit an Article
Submit a Tip
Place your Ad
Add URL
Osteoporosis Questions?
Contact Us
Related Topics:
Best Treatment For Osteoporosis
New Osteoporosis Treatment
Treatment For Osteoporosis
Latest Treatment For Osteoporosis
Other Channels:
|
 |
|
|
|
|
|
|
|
|
Recent Questions and Answers
|
|
|
|
|
|
|
|
Recent Best Treatment For Osteoporosis News:
|
|
|
Leading Australian bone and geriatric specialists have hailed the Nepean Consensus Statement meeting on the treatment of osteoporosis in the aged care setting a major success, and a significant step forward in addressing this growing national issue ...
July 28 (Bloomberg) -- Amgen Inc. and GlaxoSmithKline Plc said they will jointly market denosumab, Amgen’s novel treatment for osteoporosis that may reach annual sales of $2 billion within a decade. Glaxo will pay $120 million initially for near ...
Osteoporosis is the most common bone disease worldwide, and is a considerable health burden to the individual, health care and society. It is estimated that one in three women and one-in-five men in Ireland over the age of 50 years have osteoporosis ...
The Procter & Gamble Co. has sold Japanese market rights for its osteoporosis treatment to Ajinomoto Co. for $210 million. The deal was announced Friday by Tokyo-based Ajinomoto, which had been selling the treatment under license. The company obtains ...
TOKYO, July 31 (Reuters) - Japan's Ajinomoto Co Inc ( 2802.T ) said on Friday it has agreed to buy the patent and trademark in Japan for Procter & Gamble's ( PG.N ) osteoporosis treatment drug Risedronate for $210 million. (Reporting by Taiga Uranaka
|
|
| |
|
|
|
Additional Best Treatment For Osteoporosis Resources:
|
|
|
|
|
|
|
|
|
Want your site featured on this page?
|
|
|
|
